• 998 Citations
  • 16 h-Index
20082018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Carmen Correale is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Inflammatory Bowel Diseases Medicine & Life Sciences
Colitis Medicine & Life Sciences
Inflammation Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Microvessels Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Mucous Membrane Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

  • 998 Citations
  • 16 h-Index
  • 24 Article
  • 3 Review article
  • 1 Letter
10 Citations (Scopus)

Full interchangeability in regard to immunogenicity between the infliximab reference biologic and biosimilars CT-P13 and SB2 in inflammatory bowel disease

Fiorino, G., Ruiz-Arguello, M. B., Maguregui, A., Nagore, D., Correale, C., Radice, S., Gilardi, D., Allocca, M., Furfaro, F., Martínez, A. & Danese, S., Feb 16 2018, In : Inflammatory Bowel Diseases. 24, 3, p. 601-606 6 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Antibodies
CT-P13
Infliximab
7 Citations (Scopus)

Protumor steering of cancer inflammation by p50 nf-kb enhances colorectal cancer progression

Porta, C., Ippolito, A., Consonni, F. M., Carraro, L., Celesti, G., Correale, C., Grizzi, F., Pasqualini, F., Tartari, S., Rinaldi, M., Bianchi, P., Balzac, F., Vetrano, S., Turco, E., Hirsch, E., Laghi, L. & Sica, A., May 1 2018, In : Cancer immunology research. 6, 5, p. 578-593 16 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Inflammation
Neoplasms
Colitis
Macrophages
12 Citations (Scopus)

Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis

Van Welden, S., De Vos, M., Wielockx, B., Tavernier, S. J., Dullaers, M., Neyt, S., Descamps, B., Devisscher, L., Devriese, S., Van den Bossche, L., Holvoet, T., Baeyens, A., Correale, C., D'Alessio, S., Vanhove, C., De Vos, F., Verhasselt, B., Breier, G., Lambrecht, B. N., Janssens, S. & 5 others, Carmeliet, P., Danese, S., Elewaut, D., Laukens, D. & Hindryckx, P., Mar 1 2017, In : Journal of Pathology. 241, 4, p. 547-558 12 p.

Research output: Contribution to journalArticle

Prolyl Hydroxylases
Colitis
Macrophages
Dextran Sulfate
Lipopolysaccharides
11 Citations (Scopus)

IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy

Furfaro, F., Gilardi, D., Allocca, M., Cicerone, C., Correale, C., Fiorino, G. & Danese, S., May 4 2017, In : Expert Review of Clinical Immunology. 13, 5, p. 457-467 11 p.

Research output: Contribution to journalReview article

Interleukin-23
Crohn Disease
Cytokines
Adaptive Immunity
Therapeutics
6 Citations (Scopus)

Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients

Fiorino, G., Correale, C., Radice, S., Allocca, M., Furfaro, F., Gilardi, D., Nagore, D., Del Rio, L., Pascual, J., Martínez, A. & Danese, S., Nov 1 2017, In : Alimentary Pharmacology and Therapeutics. 46, 9, p. 903-905 3 p.

Research output: Contribution to journalLetter